Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 79 citing articles:

Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus
Richard Adeleke, Julie Sahler, Annette Choi, et al.
Science Advances (2025) Vol. 11, Iss. 5
Closed Access
Identification of conserved SARS-CoV-2 spike epitopes that expand public cTfh clonotypes in mild COVID-19 patients
Xiuyuan Lu, Yuki Hosono, Masamichi Nagae, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 12
Open Access | Times Cited: 36
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 8
Open Access | Times Cited: 12
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Franziska Günl, Angeles Mecate‐Zambrano, Selina Rehländer, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 28
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination
Fatima Amanat, Jordan Clark, Juan Manuel Carreño, et al.
Journal of Virology (2023) Vol. 97, Iss. 3
Open Access | Times Cited: 11
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 26
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats
Martijn A. Langereis, Irina C. Albulescu, Judith Stammen‐Vogelzangs, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 26
SARS-CoV-2 spike conformation determines plasma neutralizing activity
John E. Bowen, Alexandra C. Walls, Anshu Joshi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
Protein engineering responses to the COVID-19 pandemic
Ching‐Lin Hsieh, Jason S. McLellan
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102385-102385
Open Access | Times Cited: 18
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Christof Plothe, Paul E. Marik, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1308-1308
Open Access | Times Cited: 9
Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus
Fatima Amanat, Shirin Strohmeier, Philip Meade, et al.
PLoS Biology (2021) Vol. 19, Iss. 12, pp. e3001384-e3001384
Open Access | Times Cited: 20
A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
Yuexiu Zhang, Mijia Lu, Mahesh KC, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 33
Open Access | Times Cited: 15
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
Ali A. Rabaan, Abbas Al Mutair, Khalid Hajissa, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1655-1655
Open Access | Times Cited: 15
Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats
Dominique J. Burri, Louis Renz, Melanie Mueller, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 490-490
Open Access | Times Cited: 2
Baculoviral COVID-19 Delta DNA vaccine cross-protects against SARS-CoV2 variants in K18-ACE2 transgenic mice
Yuyeon Jang, Hansam Cho, Jungmin Chun, et al.
Vaccine (2023) Vol. 41, Iss. 6, pp. 1223-1231
Open Access | Times Cited: 7
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
Chih-Yun Lai, Albert To, Teri Ann S. Wong, et al.
Vaccine X (2021) Vol. 9, pp. 100126-100126
Open Access | Times Cited: 16
A Precision Adjuvant Approach to Enhance Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines Optimized for Immunologically Distinct Vulnerable Populations
David J. Dowling, Ofer Levy
Clinical Infectious Diseases (2022) Vol. 75, Iss. Supplement_1, pp. S30-S36
Open Access | Times Cited: 11
Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2
Hong-Su Park, Yumiko Matsuoka, Cindy Luongo, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Humoral and cellular immunity against diverse SARS-CoV-2 variants
Changxu Chen, Xin Wang, Zeli Zhang
Journal of genetics and genomics/Journal of Genetics and Genomics (2023) Vol. 50, Iss. 12, pp. 934-947
Closed Access | Times Cited: 6
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
Edward R. Kastenhuber, Javier A. Jaimes, Jared L. Johnson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15
Application of Baculovirus Expression Vector system (BEV) for COVID-19 diagnostics and therapeutics: a review
Muhammad Azharuddin Azali, Salmah Mohamed, Azian Harun, et al.
Journal of Genetic Engineering and Biotechnology (2022) Vol. 20, Iss. 1, pp. 98-98
Open Access | Times Cited: 10
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 1
Vaccination with ancestral SARS-CoV-2 spike adjuvanted with TLR agonists provides cross-protection against XBB.1
Stephanie K. Lathrop, Jordan Clark, Karthik Siram, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome
Alexander Bontempo, Alexandra Chirino, Alireza Heidari, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 1

Scroll to top